<!DOCTYPE HTML SYSTEM "HTML4.DTD" >
<HTML>
<HEAD>
<TITLE>ICD-10: Block E20-E35
</TITLE>
<LINK HREF="style.css" REL="stylesheet" TYPE="text/css">
<META NAME="AUTHOR" CONTENT="Michael Schopen">
<META NAME="DESCRIPTION" CONTENT="International Statistical Classification of Diseases and Related Health Problems (ICD-10). HTML files for WWW.">
<META NAME="KEYWORDS" CONTENT="ICD-10; tabular list;chapter IV">
<META NAME="COPYRIGHT" CONTENT="WHO">
<META NAME="ROBOTS" CONTENT="index, follow">
<SCRIPT TYPE="text/JavaScript">
  function openSub(URL) {
    var SUB = window.open(URL, "SUB", "dependent=1,height=200,width=500,resizable=1,scrollbars=1") ;
    SUB.focus() ;
  }
</SCRIPT>
<SCRIPT TYPE="text/JavaScript">
function setNavi(url,hash) {
  if (window.name != "SUB") {
    if ((parent.location.href == self.location.href) || (!parent.correct_frame)) {
      window.location.replace('fr-icd.htm?'+url+'+'+hash) ;
    }
    else {
      with (parent.navi.document) {
        open('text/html','replace') ;
        writeln('<HEAD>') ;
        writeln('<TITLE>Navigational frame work ICD-10</TITLE>') ;
        writeln('<link href="style.css" rel="stylesheet" type="text/css">') ;
        writeln('</HEAD>') ;
        writeln('<BODY BGCOLOR="#000080">') ;
        writeln('<table border="0" cellpadding="4" cellspacing="4" width="100%">') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="navi.htm#ka00">List&nbsp;of&nbsp;Chapters</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ke00.htm">Chapter&nbsp;Introduction</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ke00.htm#glied">List&nbsp;of&nbsp;Blocks</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ge15.htm">Previous&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ge40.htm">Next&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td>&nbsp;</td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="_top" HREF="http://www.who.int/classifications/icd">ICD Homepage</A></td></tr></table>') ;
        close() ;
      }
    }
  }
}
</SCRIPT>

</HEAD>

<BODY BGCOLOR="#FFFFFF" onLoad="setNavi('ge20.htm',window.location.hash.substring(1))">

<H1>Chapter IV
<BR>
<HR>Endocrine, nutritional and metabolic diseases
<BR>(E00-E90)
</H1>
<H2>Disorders of other endocrine glands
<BR>(E20-E35)
</H2>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">galactorrhoea 
<NOBR>(
<A HREF="gn60.htm#n643">N64.3
</A>)
</NOBR>
<BR>gynaecomastia 
<NOBR>(
<A HREF="gn60.htm#n62">N62
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e20">
</A>E20
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypoparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Di George's syndrome 
<NOBR>(
<A HREF="gd80.htm#d821">D82.1
</A>)
</NOBR>
<BR>postprocedural hypoparathyroidism 
<NOBR>(
<A HREF="ge70.htm#e892">E89.2
</A>)
</NOBR>
<BR>tetany NOS 
<NOBR>(
<A HREF="gr25.htm#r290">R29.0
</A>)
</NOBR>
<BR>transitory neonatal hypoparathyroidism 
<NOBR>(
<A HREF="gp70.htm#p714">P71.4
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e200">
</A>E20.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Idiopathic hypoparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e201">
</A>E20.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Pseudohypoparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e208">
</A>E20.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hypoparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e209">
</A>E20.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypoparathyroidism, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Parathyroid tetany
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e21">
</A>E21
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperparathyroidism and other disorders of parathyroid gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">osteomalacia:
<BR>&middot; adult 
<NOBR>(
<A HREF="gm80.htm#m83">M83.-
</A>)
</NOBR>
<BR>&middot; infantile and juvenile 
<NOBR>(
<A HREF="ge50.htm#e550">E55.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e210">
</A>E21.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primary hyperparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hyperplasia of parathyroid
<BR>Osteitis fibrosa cystica generalisata [von Recklinghausen's disease of bone]
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e211">
</A>E21.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Secondary hyperparathyroidism, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">secondary hyperparathyroidism of renal origin 
<NOBR>(
<A HREF="gn25.htm#n258">N25.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e212">
</A>E21.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hyperparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">familial hypocalciuric hypercalcaemia 
<NOBR>(
<A HREF="ge70.htm#e835">E83.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e213">
</A>E21.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperparathyroidism, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e214">
</A>E21.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified disorders of parathyroid gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e215">
</A>E21.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of parathyroid gland, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e22">
</A>E22
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperfunction of pituitary gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Cushing's syndrome 
<NOBR>(
<A HREF="#e24">E24.-
</A>)
</NOBR>
<BR>Nelson's syndrome 
<NOBR>(
<A HREF="#e241">E24.1
</A>)
</NOBR>
<BR>overproduction of:
<BR>&middot; ACTH not associated with Cushing's disease 
<NOBR>(
<A HREF="#e270">E27.0
</A>)
</NOBR>
<BR>&middot; pituitary ACTH 
<NOBR>(
<A HREF="#e240">E24.0
</A>)
</NOBR>
<BR>&middot; thyroid-stimulating hormone 
<NOBR>(
<A HREF="ge00.htm#e058">E05.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e220">
</A>E22.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acromegaly and pituitary gigantism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Arthropathy associated with acromegaly+ 
<NOBR>(
<A HREF="gm05.htm#m145">M14.5*
</A>)
</NOBR>
<BR>Overproduction of growth hormone
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">constitutional:
<BR>&middot; gigantism 
<NOBR>(
<A HREF="#e344">E34.4
</A>)
</NOBR>
<BR>&middot; tall stature 
<NOBR>(
<A HREF="#e344">E34.4
</A>)
</NOBR>
<BR>increased secretion from endocrine pancreas of growth hormone-releasing hormone 
<NOBR>(
<A HREF="ge15.htm#e168">E16.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e221">
</A>E22.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperprolactinaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e222">
</A>E22.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Syndrome of inappropriate secretion of antidiuretic hormone
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e228">
</A>E22.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hyperfunction of pituitary gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Central precocious puberty
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e229">
</A>E22.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperfunction of pituitary gland, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e23">
</A>E23
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypofunction and other disorders of pituitary gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">the listed conditions whether the disorder is in the pituitary or the hypothalamus
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">postprocedural hypopituitarism 
<NOBR>(
<A HREF="ge70.htm#e893">E89.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e230">
</A>E23.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypopituitarism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Fertile eunuch syndrome
<BR>Hypogonadotropic hypogonadism
<BR>Idiopathic growth hormone deficiency
<BR>Isolated deficiency of:
<BR>&middot; gonadotropin
<BR>&middot; growth hormone
<BR>&middot; pituitary hormone
<BR>Kallmann's syndrome
<BR>Lorain-Levi short stature
<BR>Necrosis of pituitary gland (postpartum)
<BR>Panhypopituitarism
<BR>Pituitary:
<BR>&middot; cachexia
<BR>&middot; insufficiency NOS
<BR>&middot; short stature
<BR>Sheehan's syndrome
<BR>Simmonds' disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e231">
</A>E23.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Drug-induced hypopituitarism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e232">
</A>E23.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Diabetes insipidus
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">nephrogenic diabetes insipidus 
<NOBR>(
<A HREF="gn25.htm#n251">N25.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e233">
</A>E23.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypothalamic dysfunction, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Prader-Willi syndrome 
<NOBR>(
<A HREF="gq80.htm#q871">Q87.1
</A>)
</NOBR>
<BR>Russell-Silver syndrome 
<NOBR>(
<A HREF="gq80.htm#q871">Q87.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e236">
</A>E23.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of pituitary gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Abscess of pituitary
<BR>Adiposogenital dystrophy
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e237">
</A>E23.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of pituitary gland, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e24">
</A>E24
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cushing's syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e240">
</A>E24.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Pituitary-dependent Cushing's disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Overproduction of pituitary ACTH
<BR>Pituitary-dependent hyperadrenocorticism
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e241">
</A>E24.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Nelson's syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e242">
</A>E24.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Drug-induced Cushing's syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e243">
</A>E24.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Ectopic ACTH syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e244">
</A>E24.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Alcohol-induced pseudo-Cushing's syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e248">
</A>E24.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other Cushing's syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e249">
</A>E24.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cushing's syndrome, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e25">
</A>E25
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Adrenogenital disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
<BR>female:
<BR>&middot; adrenal pseudohermaphroditism
<BR>&middot; heterosexual precocious pseudopuberty
<BR>male:
<BR>&middot; isosexual precocious pseudopuberty
<BR>&middot; macrogenitosomia praecox
<BR>&middot; sexual precocity with adrenal hyperplasia
<BR>virilization (female)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e250">
</A>E25.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Congenital adrenogenital disorders associated with enzyme deficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Congenital adrenal hyperplasia
<BR>21-Hydroxylase deficiency
<BR>Salt-losing congenital adrenal hyperplasia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e258">
</A>E25.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other adrenogenital disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Idiopathic adrenogenital disorder
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e259">
</A>E25.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Adrenogenital disorder, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Adrenogenital syndrome NOS
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e26">
</A>E26
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperaldosteronism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e260">
</A>E26.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primary hyperaldosteronism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Conn's syndrome
<BR>Primary aldosteronism due to adrenal hyperplasia (bilateral)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e261">
</A>E26.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Secondary hyperaldosteronism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e268">
</A>E26.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hyperaldosteronism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Bartter's syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e269">
</A>E26.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperaldosteronism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e27">
</A>E27
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of adrenal gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e270">
</A>E27.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other adrenocortical overactivity
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Overproduction of ACTH, not associated with Cushing's disease
<BR>Premature adrenarche
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Cushing's syndrome 
<NOBR>(
<A HREF="#e24">E24.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e271">
</A>E27.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primary adrenocortical insufficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Addison's disease
<BR>Autoimmune adrenalitis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">amyloidosis 
<NOBR>(
<A HREF="ge70.htm#e85">E85.-
</A>)
</NOBR>
<BR>tuberculous Addison's disease 
<NOBR>(
<A HREF="ga15.htm#a187">A18.7
</A>)
</NOBR>
<BR>Waterhouse-Friderichsen syndrome 
<NOBR>(
<A HREF="ga30.htm#a391">A39.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e272">
</A>E27.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Addisonian crisis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Adrenal crisis
<BR>Adrenocortical crisis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e273">
</A>E27.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Drug-induced adrenocortical insufficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e274">
</A>E27.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified adrenocortical insufficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Adrenal:
<BR>&middot; haemorrhage
<BR>&middot; infarction
<BR>Adrenocortical insufficiency NOS
<BR>Hypoaldosteronism
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">adrenoleukodystrophy [Addison-Schilder] 
<NOBR>(
<A HREF="ge70.htm#e713">E71.3
</A>)
</NOBR>
<BR>Waterhouse-Friderichsen syndrome 
<NOBR>(
<A HREF="ga30.htm#a391">A39.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e275">
</A>E27.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Adrenomedullary hyperfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Adrenomedullary hyperplasia
<BR>Catecholamine hypersecretion
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e278">
</A>E27.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified disorders of adrenal gland
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Abnormality of cortisol-binding globulin
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e279">
</A>E27.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of adrenal gland, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e28">
</A>E28
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Ovarian dysfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">isolated gonadotropin deficiency 
<NOBR>(
<A HREF="#e230">E23.0
</A>)
</NOBR>
<BR>postprocedural ovarian failure 
<NOBR>(
<A HREF="ge70.htm#e894">E89.4
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e280">
</A>E28.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Estrogen excess
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e281">
</A>E28.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Androgen excess
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hypersecretion of ovarian androgens
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e282">
</A>E28.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Polycystic ovarian syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Sclerocystic ovary syndrome
<BR>Stein-Leventhal syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e283">
</A>E28.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primary ovarian failure
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Decreased estrogen
<BR>Premature menopause NOS
<BR>Resistant ovary syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">menopausal and female climacteric states 
<NOBR>(
<A HREF="gn80.htm#n951">N95.1
</A>)
</NOBR>
<BR>pure gonadal dysgenesis 
<NOBR>(
<A HREF="gq90.htm#q991">Q99.1
</A>)
</NOBR>
<BR>Turner's syndrome 
<NOBR>(
<A HREF="gq90.htm#q96">Q96.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e288">
</A>E28.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other ovarian dysfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Ovarian hyperfunction NOS
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e289">
</A>E28.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Ovarian dysfunction, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e29">
</A>E29
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Testicular dysfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">androgen resistance syndrome 
<NOBR>(
<A HREF="#e345">E34.5
</A>)
</NOBR>
<BR>azoospermia or oligospermia NOS 
<NOBR>(
<A HREF="gn40.htm#n46">N46
</A>)
</NOBR>
<BR>isolated gonadotropin deficiency 
<NOBR>(
<A HREF="#e230">E23.0
</A>)
</NOBR>
<BR>Klinefelter's syndrome 
<NOBR>(
<A HREF="gq90.htm#q980">Q98.0-Q98.2
</A>, 
<A HREF="gq90.htm#q984">Q98.4
</A>)
</NOBR>
<BR>postprocedural testicular hypofunction 
<NOBR>(
<A HREF="ge70.htm#e895">E89.5
</A>)
</NOBR>
<BR>testicular feminization (syndrome) 
<NOBR>(
<A HREF="#e345">E34.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e290">
</A>E29.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Testicular hyperfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hypersecretion of testicular hormones
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e291">
</A>E29.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Testicular hypofunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Defective biosynthesis of testicular androgen NOS
<BR>5-Alpha-reductase deficiency (with male pseudohermaphroditism)
<BR>Testicular hypogonadism NOS
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e298">
</A>E29.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other testicular dysfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e299">
</A>E29.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Testicular dysfunction, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e30">
</A>E30
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of puberty, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e300">
</A>E30.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Delayed puberty
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Constitutional delay of puberty
<BR>Delayed sexual development
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e301">
</A>E30.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Precocious puberty
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Precocious menstruation
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Albright(-McCune)(-Sternberg) syndrome 
<NOBR>(
<A HREF="gq65.htm#q781">Q78.1
</A>)
</NOBR>
<BR>central precocious puberty 
<NOBR>(
<A HREF="#e228">E22.8
</A>)
</NOBR>
<BR>congenital adrenal hyperplasia 
<NOBR>(
<A HREF="#e250">E25.0
</A>)
</NOBR>
<BR>female heterosexual precocious pseudopuberty 
<NOBR>(
<A HREF="#e25">E25.-
</A>)
</NOBR>
<BR>male isosexual precocious pseudopuberty 
<NOBR>(
<A HREF="#e25">E25.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e308">
</A>E30.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of puberty
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Premature thelarche
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e309">
</A>E30.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of puberty, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e31">
</A>E31
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Polyglandular dysfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">ataxia telangiectasia [Louis-Bar] 
<NOBR>(
<A HREF="gg10.htm#g113">G11.3
</A>)
</NOBR>
<BR>dystrophia myotonica [Steinert] 
<NOBR>(
<A HREF="gg70.htm#g711">G71.1
</A>)
</NOBR>
<BR>pseudohypoparathyroidism 
<NOBR>(
<A HREF="#e201">E20.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e310">
</A>E31.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Autoimmune polyglandular failure
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Schmidt's syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e311">
</A>E31.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Polyglandular hyperfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">multiple endocrine adenomatosis 
<NOBR>(
<A HREF="gd37.htm#d448">D44.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e318">
</A>E31.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other polyglandular dysfunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e319">
</A>E31.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Polyglandular dysfunction, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e32">
</A>E32
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Diseases of thymus
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">aplasia or hypoplasia with immunodeficiency 
<NOBR>(
<A HREF="gd80.htm#d821">D82.1
</A>)
</NOBR>
<BR>myasthenia gravis 
<NOBR>(
<A HREF="gg70.htm#g700">G70.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e320">
</A>E32.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Persistent hyperplasia of thymus
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hypertrophy of thymus
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e321">
</A>E32.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Abscess of thymus
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e328">
</A>E32.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other diseases of thymus
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e329">
</A>E32.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disease of thymus, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e34">
</A>E34
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other endocrine disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">pseudohypoparathyroidism 
<NOBR>(
<A HREF="#e201">E20.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e340">
</A>E34.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Carcinoid syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Note:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">May be used as an additional code, if desired, to identify functional activity associated with a carcinoid tumour.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e341">
</A>E34.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hypersecretion of intestinal hormones
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e342">
</A>E34.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Ectopic hormone secretion, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e343">
</A>E34.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Short stature, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Short stature:
<BR>&middot; NOS
<BR>&middot; constitutional
<BR>&middot; Laron-type
<BR>&middot; psychosocial
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">progeria 
<NOBR>(
<A HREF="#e348">E34.8
</A>)
</NOBR>
<BR>Russell-Silver syndrome 
<NOBR>(
<A HREF="gq80.htm#q871">Q87.1
</A>)
</NOBR>
<BR>short-limbed stature with immunodeficiency 
<NOBR>(
<A HREF="gd80.htm#d822">D82.2
</A>)
</NOBR>
<BR>short stature:
<BR>&middot; achondroplastic 
<NOBR>(
<A HREF="gq65.htm#q774">Q77.4
</A>)
</NOBR>
<BR>&middot; hypochondroplastic 
<NOBR>(
<A HREF="gq65.htm#q774">Q77.4
</A>)
</NOBR>
<BR>&middot; in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
<BR>&middot; nutritional 
<NOBR>(
<A HREF="ge40.htm#e45">E45
</A>)
</NOBR>
<BR>&middot; pituitary 
<NOBR>(
<A HREF="#e230">E23.0
</A>)
</NOBR>
<BR>&middot; renal 
<NOBR>(
<A HREF="gn25.htm#n250">N25.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e344">
</A>E34.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Constitutional tall stature
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Constitutional gigantism
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e345">
</A>E34.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Androgen resistance syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Male pseudohermaphroditism with androgen resistance
<BR>Peripheral hormonal receptor disorder
<BR>Reifenstein's syndrome
<BR>Testicular feminization (syndrome)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e348">
</A>E34.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified endocrine disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Pineal gland dysfunction
<BR>Progeria
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e349">
</A>E34.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Endocrine disorder, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Disturbance:
<BR>&middot; endocrine NOS
<BR>&middot; hormone NOS
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e35">
</A>E35*
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of endocrine glands in diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e350">
</A>E35.0*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of thyroid gland in diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Tuberculosis of thyroid gland 
<NOBR>(
<A HREF="ga15.htm#a188">A18.8+
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e351">
</A>E35.1*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of adrenal glands in diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Tuberculous Addison's disease 
<NOBR>(
<A HREF="ga15.htm#a187">A18.7+
</A>)
</NOBR>
<BR>Waterhouse-Friderichsen syndrome (meningococcal) 
<NOBR>(
<A HREF="ga30.htm#a391">A39.1+
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e358">
</A>E35.8*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of other endocrine glands in diseases classified elsewhere
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<HR>
<TABLE BORDER="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="33%">Processed on 03.06.2003 
<A HREF="mailto:schopen@dimdi.de">M.S.
</A>
</TD>
<TD VALIGN="TOP" ALIGN="CENTER" WIDTH="34%">Source: World Health Organization
</TD>
<TD VALIGN="TOP" ALIGN="RIGHT" WIDTH="33%">&copy; Copyright WHO 1994/2003
</TD>
</TR>
</TABLE>
</BODY >
</HTML>
